Woodline Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.72M | Sell |
|
|||||
|
2025
Q1 | $9.27M | Buy |
|
|||||
|
2024
Q4 | $3.18M | Buy |
|
|||||
|
2024
Q3 | $2.57M | Sell |
|
|||||
|
2024
Q2 | $2.86M | Sell |
|
|||||
|
2024
Q1 | $10.5M | Sell |
|
|||||
|
2023
Q4 | $11.8M | Hold |
|
|||||
|
2023
Q3 | $9.58M | Buy |
|
|||||
|
2023
Q2 | $5.68M | Sell |
|
|||||
|
2023
Q1 | $8.05M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.13M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $261K | Buy |
|